Analytical Data
-
Gene name
C19orf48
- Application
-
Alternative Names
Multidrug resistance-related protein
-
Species
Human
-
Source
E. coli
-
Tag
N- GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q6RUI8
-
Expression Region
1-117aa
-
Molecular Weight
40.1 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C19orf48, also known as the Calcium-Dependent Membrane Protein 1 (CDMP1), has garnered attention in recent years due to its potential role in various biological processes and diseases. Research indicates that C19orf48 may be involved in calcium signaling pathways and membrane dynamics, which are critical for numerous cellular functions, including cell proliferation, differentiation, and apoptosis. Its expression profile suggests that it may have important implications in specific tissue types, particularly in the nervous system and immune response. Additionally, aberrant regulation of C19orf48 has been associated with several pathological conditions, including cancer and neurological disorders. Given these insights, recombinant proteins of C19orf48 are being studied to elucidate its functional mechanisms and interactions at the molecular level. By generating and characterizing recombinant C19orf48, researchers aim to better understand its biological role, paving the way for potential therapeutic applications. This involves using techniques such as protein expression in heterologous systems, purification, and functional assays to assess its properties and biological activities. Overall, the study of C19orf48 and its recombinant forms holds promise for advancing our understanding of its significance in health and disease.
